Gordian Capital (Singapore)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Hold |
6,500
| – | – | 0.66% | 32 |
|
|
2025
Q1 | $451K | Hold |
6,500
| – | – | 0.28% | 51 |
|
|
2024
Q4 | $557K | Buy |
6,500
+3,002
| +86% | +$257K | 0.29% | 54 |
|
|
2024
Q3 | $417K | Sell |
3,498
-3,602
| -51% | -$429K | 0.16% | 64 |
|
|
2024
Q2 | $1.01M | Buy |
7,100
+2,100
| +42% | +$300K | 0.58% | 31 |
|
|
2024
Q1 | $642K | Buy |
5,000
+2,000
| +67% | +$257K | 0.48% | 30 |
|
|
2023
Q4 | $310K | Buy |
+3,000
| New | +$310K | 0.28% | 35 |
|
|
2022
Q2 | – | Sell |
-1,700
| Closed | -$85K | – | 143 |
|
|
2022
Q1 | $85K | Hold |
1,700
| – | – | 0.07% | 63 |
|
|
2021
Q4 | $96K | Buy |
+1,700
| New | +$96K | 0.08% | 74 |
|